New BARDA Award: 98point6 USA Product Name: Text
Post# of 36537
(Total Views: 453)
Posted On: 09/13/2020 5:31:47 PM
New BARDA Award: 98point6 USA
Product Name: Text-based virtual care to assess, diagnose and treat COVID-19
Description:
The 98point6 primary care platform combines a telehealth service with AI and machine learning to provide a comprehensive program of diagnosis, assessment, triage, reporting and tracking of SARS-CoV-2 infections to a national population of patients.
Unique Impact:
The ability to assess data daily across a national population allows real-time comparison of geographic patterns of infection. By combining ease of access and little to no cost per visit, 98point6 encourages patients to seek care at the earliest stages of illness.
Base Award Amount: $700,000.00 (September 10, 2020)
Cost Share: Yes
Product Name: Text-based virtual care to assess, diagnose and treat COVID-19
Description:
The 98point6 primary care platform combines a telehealth service with AI and machine learning to provide a comprehensive program of diagnosis, assessment, triage, reporting and tracking of SARS-CoV-2 infections to a national population of patients.
Unique Impact:
The ability to assess data daily across a national population allows real-time comparison of geographic patterns of infection. By combining ease of access and little to no cost per visit, 98point6 encourages patients to seek care at the earliest stages of illness.
Base Award Amount: $700,000.00 (September 10, 2020)
Cost Share: Yes
(0)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼